|
16 Jun 2011 |
Inviragen Initiates Phase 1 Study of Hand, Foot and Mouth Disease Vaccine in Singapore
|
|
16 Jun 2011 |
BiondVax Announces Positive Phase IIa Results for Universal Flu Vaccine
|
|
14 Jun 2011 |
Arecor and GSK Form Collaboration to Advance New Vaccines
|
|
14 Jun 2011 |
GSK to purchase Shenzhen Neptunus stake in previously formed joint venture for influenza vaccines in China
|
|
13 Jun 2011 |
Circassia's Rapid Four-Dose ToleroMune Treatment Maintains Significant Reduction in Allergy Symptoms During 12-Month Follow-up
|
|
10 Jun 2011 |
The Juvenile Diabetes Research Foundation and Selecta Biosciences Enter Research Collaboration for Vaccines for Type 1 Diabetes
|
|
09 Jun 2011 |
ImmunoCellular Therapeutics Ltd. Expands Phase II Trial of ICT-107
|
|
09 Jun 2011 |
Isconova enters into adjuvant license agreement with Crucell
|
|
08 Jun 2011 |
Medicago reports positive U.S. clinical trial results for its H1N1 / seasonal influenza vaccine
|
|
08 Jun 2011 |
Merck and Intercell AG Announce Termination of Phase II/III Clinical Trial of Investigational Staphylococcus aureus Vaccine, V710
|
|
08 Jun 2011 |
RXi Pharmaceuticals Presents Additional Positive Phase 2 Efficacy Results for Combination of NeuVaxTM (E75) and Trastuzumab Breast Cancer at ASCO
|
|
06 Jun 2011 |
Vaxart Begins First Oral Vaccine Clinical Trial
|
|
06 Jun 2011 |
Vaxart, Inc., a San Francisco biotechnology company developing oral-delivery vaccines, has begun dosing volunteers in a Phase I clinical trial
|
|
06 Jun 2011 |
BioSante Pharmaceuticals Announces Lifting of Clinical Hold on GVAX Prostate Cancer Vaccine
|
|
06 Jun 2011 |
Stemline Therapeutics, Inc. Announces Oral Presentation of Positive Phase I/II Trial Results with Novel Brain Cancer Vaccine at the American Society of Clinical Oncology (ASCO) 2011 Annual Meeting
|
|
06 Jun 2011 |
New Data From Phase 2 Brain Cancer Study With Prophage Series G-200 (HSPPC-96) Shows Improved Overall Survival
|
|
06 Jun 2011 |
Cellectis and VitamFero Collaborate to Develop Vaccines against Parasitic Infection
|
|
02 Jun 2011 |
Fraunhofer USA CMB Announces Positive Phase 1 Interim Results for Its Plant-Produced H1N1 Influenza Vaccine
|
|
01 Jun 2011 |
GlobeImmune Reports Positive Results for Two Therapeutic Vaccines, GI-4000 and GI-6207
|
|
01 Jun 2011 |
Immunovaccine Announces Immune Results from Phase I Trial for DPX-0907 Therapeutic Cancer Vaccine
|
|
01 Jun 2011 |
Diamyd regains control of diabetes therapy
|
|
01 Jun 2011 |
Profectus BioSciences Announces Initiation of Phase I Clinical Trial to Evaluate Safety and Immunogenicity of a Vesicular Stomatitis Virus-vectored HIV-1 Vaccine
|
|
26 May 2011 |
Medicago announces research collaboration for the development of a VLP vaccine candidate for the prevention of Ebola with the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID)
|
|
26 May 2011 |
Dynavax Completes Phase 3 Study of HEPLISAV(TM)
|
|
26 May 2011 |
Isconova initiates influenza study vaccinations
|
